David Slays Goliath: Exceptional Efficacy of Oral Vinorelbine in Conquering Metastatic Finger Angiosarcoma
Angiosarcoma (AS) is a rare and aggressive disease originating from blood or lymphatic vessel endothelium, representing <1% of soft-tissue sarcomas. The prognosis is generally poor, with a 5-year survival rate of only 30%–50%. The recurrence rate is high, and metastasis occurs in about half of th...
Saved in:
Main Authors: | Te-Lin Hsu, San-Chi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
Series: | Journal of Cancer Research and Practice |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ejcrp.eJCRP-D-23-00033 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tactics of the treatment of left atrial angiosarcoma
by: R.M. Vitovskyi, et al.
Published: (2019-10-01) -
Development and validation of a prognostic nomogram model in primary cutaneous and subcutaneous soft tissue angiosarcoma
by: Jinqian Mao, et al.
Published: (2022-07-01) -
A Case Report of Angiosarcoma of the Tongue: A Diagnostic Dilemma at Presentation
by: Shilajit Bhattacharya, et al.
Published: (2023-04-01) -
WGCNA and integrative network analysis identify CHRNA5 and CTLA4 as potential therapeutic targets against angiosarcoma
by: Trishla Bhatnagar, et al.
Published: (2024-01-01) -
Investigating intra‐tumoural heterogeneity and microenvironment diversity in primary cardiac angiosarcoma through single‐cell RNA sequencing
by: Jingyuan Huo, et al.
Published: (2024-12-01)